Moderna COVID-19 vaccine clears key safety hurdle in mouse study

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

A study of Moderna Inc’s COVID-19 vaccine in mice lends some assurance that it will not increase the risk of more severe disease, and that one dose may provide protection against the novel coronavirus, according to preliminary data released on Friday.

Prior studies on a vaccine for SARS – a close cousin to the new virus that causes COVID-19 – suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the pathogen, especially in individuals who do not produce an adequately strong immune response.

Scientists have seen this risk as a key hurdle that must be cleared before vaccines can be safely tested in thousands of healthy people.

While the data released by the U.S. National Institutes of Allergy and Infectious Disease (NIAID) and Moderna was encouraging, mouse data is no guarantee of what will happen in humans.

The vaccine is currently in midstage testing in healthy volunteers. Moderna said on Thursday it plans to begin final-stage trials enrolling 30,000 people in July.

In the new study, six-week-old mice received one or two shots of a variety of doses of Moderna’s vaccine, including doses considered not strong enough to elicit a protective immune response. Researchers then exposed the mice to the virus.

Subsequent analyses looking for signs of disease enhancement suggests that “sub-protective” immune responses do not cause what is known as vaccine-associated enhanced respiratory disease, a susceptibility to more severe disease in the lungs.

“Subprotective doses did not prime mice for enhanced immunopathology following (exposure),” Dr. Barney Graham of the Vaccine Research Center at NIAID and colleagues wrote in the not yet peer reviewed manuscript, posted on the bioRxiv website.

Further testing also suggested that the vaccine induces potent neutralizing antibody responses – the type of response needed to block the virus from infecting cells.

This article was originally posted on finance.yahoo.com/news/.
Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

This is Why Bradley Cooper Was Way More Involved in the Making of ‘Joker’ than You Realized

Joker fans, you have Bradley Cooper to thank for your new favorite film. The divisive discourse around Joker made the film one of 2019’s most-talked-about releases. We’re certain...

Mesothelioma Attorney – Is the Diagnosis Medically Necessary?

Mesothelioma Attorney - Is the Diagnosis Medically Necessary?A person may have Mesothelioma, but only a physician can diagnose the disease. Because of this,...

How China could use this moment to charge ahead with its geopolitical agenda

China, the world’s second largest economy, is under threat as the pandemic wipes out jobs and slows productivity and growth. But even with the economic...

Netflix Vs The Competition

When it comes to Netflix, anyone who watches television, or movies at all, will quickly be hooked. Not only can you watch as many...

European Banks Are Set for Relief on Sovereign Bond Holdings

European banks are close to receiving capital relief on their holdings of sovereign debt as lawmakers bolster a package of measures intended to protect...
Home of Science
Follow me